Discovery Tools (Healthcare) · Lexington, MA · Founded 2019 · Privately Held (backing)
Operator of a pharmaceutical company intended to discover and develop molecular glues. TRIANA Biomedicines is based in Lexington, MA and was founded in 2019. It was valued at $258 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $246 million across 2 recorded rounds; the latest was a $120 million Series B in Nov 2025.
PMV mark · valuation
$258.0M
Oct 2026
Priced at
its later-stage round
Nov 2025
Total raised
$246.1M
Last round
Later Stage VC (Series B)
Nov 2025
Cap table — not yet on record
TRIANA Biomedicines's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of TRIANA Biomedicines with a free account
·The complete investor list: 12 names
·Everyone on the team, board and advisors included
·Watch TRIANA Biomedicines: the Monday email on marks, rounds and moves
Where does TRIANA Biomedicines's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across TRIANA Biomedicines's 2 recorded funding rounds.
